|
Market Closed -
Other stock markets
|
Pre-market 07:28:52 am | |||
| 34.28 USD | +4.54% |
|
34.36 | +0.25% |
| Jul. 10 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
| Jul. 10 | Sector Update: Health Care Stocks Rise Thursday Afternoon | MT |
| Capitalization | 13.26B 11.34B 10.57B 9.77B 18.14B 1,137B 20.2B 126B 48.27B 531B 49.72B 48.7B 1,941B | P/E ratio 2025 * |
-3.39x | P/E ratio 2026 * | -4.63x |
|---|---|---|---|---|---|
| Enterprise value | 7.87B 6.73B 6.27B 5.8B 10.76B 674B 11.98B 74.98B 28.64B 315B 29.5B 28.89B 1,152B | EV / Sales 2025 * |
0.94x | EV / Sales 2026 * | 4.32x |
| Free-Float |
90.48% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Moderna, Inc.
More recommendations
More press releases
More news
| 1 day | +0.36% | ||
| 1 week | +12.43% | ||
| Current month | +24.25% | ||
| 1 month | +23.84% | ||
| 3 months | +39.92% | ||
| 6 months | -18.86% | ||
| Current year | -17.56% |
| 1 week | 29.72 |  | 34.39 |
| 1 month | 25.06 | | 34.39 |
| Current year | 23.15 | | 48.92 |
| 1 year | 23.15 | | 129.39 |
| 3 years | 23.15 | | 217.25 |
| 5 years | 23.15 | | 497.49 |
| 10 years | 11.54 | | 497.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 52 | 2011-02-28 |
James Mock
DFI | Director of Finance/CFO | 48 | 2022-09-05 |
Stephen Hoge
PSD | President | 49 | 2024-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Sagan
BRD | Director/Board Member | 66 | 2018-05-31 |
Noubar Afeyan
CHM | Chairman | 62 | 2012-01-31 |
Stéphane Bancel
BRD | Director/Board Member | 52 | 2011-02-28 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.54% | +12.43% | -70.81% | -80.55% | 13.26B | ||
| -0.61% | -0.03% | -19.06% | -16.34% | 77.04B | ||
| +1.30% | +2.27% | -47.74% | -9.94% | 59.15B | ||
| +6.09% | +8.00% | +35.68% | +31.87% | 55.99B | ||
| +1.35% | +3.54% | +19.90% | +100.84% | 38.34B | ||
| +1.74% | +1.85% | -41.86% | -38.15% | 19.83B | ||
| +6.02% | +14.39% | +71.05% | +743.19% | 17.48B | ||
| +1.31% | -4.26% | +124.38% | +122.22% | 17.48B | ||
| -0.04% | -.--% | +70.62% | +129.06% | 14.02B | ||
| +2.36% | +2.76% | +15.82% | -12.60% | 13.62B | ||
| Average | +1.95% | +4.00% | +15.80% | +96.96% | 32.62B | |
| Weighted average by Cap. | +1.89% | +3.07% | +4.05% | +57.46% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.07B 1.77B 1.65B 1.53B 2.83B 178B 3.15B 19.74B 7.54B 82.95B 7.76B 7.6B 303B | 2.4B 2.05B 1.91B 1.77B 3.28B 206B 3.66B 22.88B 8.74B 96.17B 9B 8.82B 351B |
| Net income | 1.33B 1.14B 1.06B 980M 1.82B 114B 2.02B 12.67B 4.84B 53.23B 4.98B 4.88B 195B | 1.92B 1.64B 1.53B 1.41B 2.62B 164B 2.92B 18.26B 6.97B 76.75B 7.18B 7.04B 281B |
| Net Debt | -5.39B -4.61B -4.3B -3.98B -7.38B -462B -8.22B -51.4B -19.63B -216B -20.22B -19.81B -790B | -2.88B -2.46B -2.29B -2.12B -3.94B -247B -4.38B -27.42B -10.47B -115B -10.79B -10.57B -421B |
More financial data
* Estimated data
Employees
5,800
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-10 | 34.28 $ | +4.54% | 11,693,076 |
| 25-07-09 | 32.79 $ | +0.77% | 9,819,691 |
| 25-07-08 | 32.54 $ | +8.83% | 19,295,041 |
| 25-07-07 | 29.90 $ | -1.94% | 8,221,852 |
| 25-07-03 | 30.49 $ | +0.69% | 6,972,646 |
Delayed Quote Nasdaq, July 10, 2025 at 04:00 pm EDT
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
34.28USD
Average target price
47.59USD
Spread / Average Target
+38.83%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MRNA Stock
Select your edition
All financial news and data tailored to specific country editions
